A detailed history of Bank Of America Corp transactions in Immatics N.V. stock. As of the latest transaction made, Bank Of America Corp holds 44,724 shares of IMTX stock, worth $545,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,724
Previous 30,243 47.88%
Holding current value
$545,185
Previous $317,000 63.72%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $141,624 - $195,348
14,481 Added 47.88%
44,724 $519,000
Q1 2024

May 15, 2024

BUY
$10.23 - $12.94 $289,488 - $366,176
28,298 Added 1454.91%
30,243 $317,000
Q4 2023

Feb 14, 2024

SELL
$7.36 - $10.89 $165,357 - $244,665
-22,467 Reduced 92.03%
1,945 $20,000
Q2 2023

Aug 14, 2023

SELL
$5.92 - $12.72 $328,358 - $705,527
-55,466 Reduced 69.44%
24,412 $281,000
Q1 2023

May 12, 2023

SELL
$6.74 - $9.44 $30,424 - $42,612
-4,514 Reduced 5.35%
79,878 $551,000
Q4 2022

Feb 10, 2023

BUY
$8.05 - $11.58 $168,929 - $243,006
20,985 Added 33.1%
84,392 $735,000
Q3 2022

Nov 14, 2022

SELL
$3.31 - $13.06 $28,591 - $112,812
-8,638 Reduced 11.99%
63,407 $634,000
Q2 2022

Aug 12, 2022

BUY
$6.0 - $9.37 $208,236 - $325,195
34,706 Added 92.95%
72,045 $627,000
Q1 2022

May 16, 2022

BUY
$6.64 - $12.85 $4,960 - $9,598
747 Added 2.04%
37,339 $298,000
Q4 2021

Feb 08, 2022

BUY
$10.81 - $14.38 $85,961 - $114,349
7,952 Added 27.77%
36,592 $491,000
Q3 2021

Nov 15, 2021

BUY
$11.58 - $15.46 $320,094 - $427,345
27,642 Added 2769.74%
28,640 $372,000
Q2 2021

Sep 13, 2021

BUY
$10.43 - $12.81 $10,409 - $12,784
998 New
998 $12,000

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $929M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.